Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer
JAMA · 2024
DOI: 10.1001/jama.2024.19585 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift JAMA, 2024. Verfasst von L Lee Dupuis und 28 weiteren Autor:innen. Beteiligte Einrichtung: Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Neoplasms, Symptom Assessment. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, CIHR.
Abstract (Originalsprache)
Importance Pediatric patients with cancer commonly experience severely bothersome symptoms. The effectiveness of routine symptom screening with symptom feedback and symptom management care pathways is unknown.
Objective
To determine whether thrice-weekly symptom screening with symptom feedback and management care pathways, compared with usual care, improves overall self-reported symptom scores measured by the Symptom Screening in Pediatrics Tool (SSPedi) in pediatric patients with cancer. Design, Setting, and Participants This cluster randomized trial enrolled participants between July 2021 and August 2023 from 20 pediatric cancer centers in the US. Patients newly diagnosed with cancer aged 8 to 18 years receiving any cancer treatment were included. Twenty sites were randomized to provide symptom screening (n = 10) vs usual care (n = 10); 221 participants were enrolled at intervention sites and 224 participants at control sites. The date of final follow-up was October 18, 2023.
Intervention
Symptom screening included providing thrice-weekly symptom screening prompts to participants, email alerts to the health care team, and locally adapted symptom management care pathway implementation. Main Outcomes and Measures The primary outcome was self-reported total SSPedi score at week 8 (range, 0-60; higher scores indicate more bothersome). Secondary outcomes were Patient-Reported Outcomes Measurement Information System Fatigue score (mean [SD] score, 50 [10]; higher scores indicate more fatigue), Pediatric Quality of Life 3.0 Acute Cancer Module scores (range, 0-100; higher scores indicate better health), symptom documentation and interventions at week 8, and unplanned health care encounters.
Results
A total of 445 participants (median [range] age, 14.8 [8.1-18.9] years; 58.9% males) were enrolled. The mean (SD) 8-week SSPedi score was 7.9 (7.2) in the symptom screening group vs 11.4 (8.7) in the usual care group. Symptom screening was associated with significantly better 8-week total SSPedi scores (adjusted mean difference, −3.8 [95% CI, −6.4 to −1.2]) and less bothersome individual symptoms, with 12 of 15 symptoms being statistically significantly reduced. There was no difference in fatigue or quality of life. The mean (SD) number of emergency department visits was 0.77 (1.12) in the symptom screening group and 0.45 (0.81) in the usual care group. There were significantly more emergency department visits in the symptom screening group (rate ratio, 1.72 [95% CI, 1.03-2.87]).
Conclusions
Symptom screening with symptom feedback and symptom management care pathways was associated with improved symptom scores and increased symptom-specific interventions. Future work should integrate symptom screening into routine clinical care. Trial Registration ClinicalTrials.gov Identifier: NCT04614662
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Pharmacy, The Hospital for Sick Children and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
- Pediatric Hematology Oncology, University of Texas Health Science Center at San Antonio, San Antonio.
- Columbia University School of Nursing/Herbert Irving Cancer Center, New York, New York.
- Division of Public Health Sciences, Washington University School of Medicine, St Louis, Missouri.
- Division of Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, California.
Förderung
- NCI NIH HHS
- CIHR
Zitieren
APA
Dupuis, L. L., Vettese, E., Grimes, A. C., Beauchemin, M. P., Klesges, L. M., Baggott, C., Demedis, J., Aftandilian, C., Freyer, D. R., Crellin-Parsons, N., Orgel, E., Dickens, D., Kelly, K. M., Kyono, W., Walsh, A., Sherani, F., Cannone, D., Orsey, A. D., King, A. A., …, & Sung, L. (2024). Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer. JAMA. https://doi.org/10.1001/jama.2024.19585
Vancouver
Dupuis LL, Vettese E, Grimes AC, Beauchemin MP, Klesges LM, Baggott C, et al. Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer. JAMA. 2024. doi:10.1001/jama.2024.19585
BibTeX
@article{Dupuis2024,
author = {Dupuis, L Lee and Vettese, Emily and Grimes, Allison C and Beauchemin, Melissa P and Klesges, Lisa M and Baggott, Christina and Demedis, Jenna and Aftandilian, Catherine and Freyer, David R and Crellin-Parsons, Nicole and Orgel, Etan and Dickens, David and Kelly, Kara M and Kyono, Wade and Walsh, Alexandra and Sherani, Farha and Cannone, Daniel and Orsey, Andrea D and King, Allison A and Yu, Lolie and Woods-Swafford, Wendy and Bradfield, Scott M and Roth, Michael E and Esbenshade, Adam J and Caywood, Emi H and Agarwal, Vibhuti and Nagasubramanian, Ramamoorthy and Tomlinson, George A and Sung, Lillian},
title = {Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.19585}
}
EUVIMED